An exploration of the barriers to the confident diagnosis of irritable bowel syndrome: A survey among general practitioners, gastroenterologists and experts in five European countries

United European Gastroenterology Journal

Volumn 3, Issue 1, 2015, Pages 39-52

  Andresen, Viola ^a   Whorwell, Peter ^b   Fortea, Josep ^c   Auzière, Sébastien ^d  

^a ISRAELITISCHES KRANKENHAUS   (Germany)

^b WYTHENSHAWE HOSPITAL   (United Kingdom)

^c Almirall ^*  (Spain)

^d KANTAR HEALTH   (United States)

Author keywords

Chronic constipation; Diagnostic approach; Guidelines; IBS C

Indexed keywords

ADULT; ARTICLE; COLONOSCOPY; CONSTIPATION; DECISION MAKING; DIARRHEA; FEMALE; GASTROENTEROLOGIST; GENERAL PRACTITIONER; HEALTH SURVEY; HUMAN; INFLAMMATORY BOWEL DISEASE; IRRITABLE COLON; MALE; PRIORITY JOURNAL; PROFESSIONAL SECRECY; QUESTIONNAIRE; THYROID FUNCTION TEST;

EID: 85006220618     PISSN: 20506406     EISSN: 20506414     Source Type: Journal    
DOI: 10.1177/2050640614558344     Document Type: Article

References (15)

1. Longstreth GF, Thompson WG, Chey WD, et al. Functional bowel disorders. Gastroenterology 2006; 130: 1480–1491.
2. Bradesi S, McRoberts JA, Anton PA, et al. Inflammatory bowel disease and irritable bowel syndrome: Separate or unified? Curr Opin Gastroenterol 2003; 19: 336–342.
3. Spiegel BM, Farid M, Esraelian E, et al. Is irritable bowel syndrome a diagnosis of exclusion? A survey of primary care providers, gastroenterologists, and IBS experts. Am J Gastroenterol 2010; 105: 848–858.
4. Fitch K, Bernstein SJ, Aguilar MD, et al. The RAND/UCLA Appropriateness method user’s manual. Santa Monica, CA: RAND, http://www.rand.org/content/dam/rand/pubs/monograph_reports/2011/MR1269.pdf (2001, accessed).
5. Cash BD, Schoenfeld P and Chey WD. The utility of diagnostic tests in irritable bowel syndrome patients: A systematic review. Am J Gastroenterol 2002; 97: 2812–2819.
6. Brandt LJ, Chey WD, Foxx-Orenstein AE, et al. An evidence-based position statement on the management of irritable bowel syndrome. Am J Gastroenterol 2009; 104(Suppl 1): S1–S35.
7. Ford AC, Bercik P, Morgan DG, et al. Validation of the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care. Gastroenterology 2013; 145: 1262–1270.
8. Jiang X, Locke GR, Choung RS, et al. Prevalence and risk factors for abdominal bloating and visible distention: A population-based study. Gut 2008; 57: 756–763.
9. Pimentel M, Talley NJ, Quigley EM, et al. Report from the multinational irritable bowel syndrome initiative 2012. Gastroenterology 2013; 144: e1–e5.
10. Rey E, Balboa A and Mearin F. Chronic constipation, irritable bowel syndrome with constipation and constipation with pain/discomfort: Similarities and differences. Am J Gastroenterol 2014; 109: 876–884.
11. Shekhar C, Monaghan PJ, Morris J, et al. Rome III functional constipation and irritable bowel syndrome with constipation are similar disorders within a spectrum of sensitization, regulated by serotonin. Gastroenterology 2013; 145: 749–757.
12. Stabell N, Stubhaug A, Flægstad T, et al. Increased pain sensitivity among adults reporting irritable bowel syndrome symptoms in a large population-based study. Pain 2013; 154: 385–392.
13. Wong RK, Palsson OS, Turner MJ, et al. Inability of the Rome III criteria to distinguish functional constipation from constipation-subtype irritable bowel syndrome. Am J Gastroenterol 2010; 105: 2228–2234.
14. Andresen V, Keller J, Pehl C, et al. Irritable bowel syndrome—the main recommendations. Dtsch Arztebl Int 2011; 108: 751–760.
15. Peabody JW, Luck J, Glassman P, et al. Measuring the quality of physician practice by using clinical vignettes: A prospective validation study. Ann Intern Med 2004; 141: 771–780.